Pinnacle Associates LTD Lannett CO Inc Transaction History

Pinnacle Associates LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$4.75 - $14.5 $78,066 - $238,307	-16,435 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$13.3 - $17.45 $76,142 - $99,901	5,725 Added 53.45%	16,435 $224,000
Q1 2018 May 11, 2018	SELL	$14.7 - $24.95 $146,706 - $249,001	-9,980 Reduced 48.24%	10,710 $172,000
Q4 2017 Feb 12, 2018	SELL	$19.9 - $29.25 $267,555 - $393,266	-13,445 Reduced 39.39%	20,690 $480,000
Q3 2017 Nov 13, 2017	SELL	$15.1 - $19.25 $97,772 - $124,643	-6,475 Reduced 15.94%	34,135 $630,000
Q2 2017 Aug 09, 2017	BUY	N/A	40,610	40,610 $828,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Associates LTD with notifications on news.